Search results for "Progression"

showing 10 items of 1251 documents

Identifying Problematic Study Progression and “At-Risk” Students in Higher Education in Finland

2018

Finland offers a specific example of a country with a broad enrolment in higher education, where the educational starting age is relatively high and where studies may last considerably longer than in most other European countries. This study attempted to identify at-risk students in Finnish universities with the greatest probability of non-completion of studies. This probability is by far the highest in the fields of information technology and information sciences and, in specific cases, in the fields of mathematics and science and economics and management. The situation of at-risk students is best described in terms of the scant use of time for present studies, uncertainty regarding their …

Higher educationdropout riskEconomics educationPredictor variablesScience educationEducationopintojen kestoopintojen keskeyttäminen0501 psychology and cognitive sciencesuniversity studentsyliopistotAt-risk studentsMedical educationManagement developmentopiskelijatbusiness.industry05 social sciences050301 educationInformation technologyriskitekijätsuoriutuminennon-completion of studieskorkeakouluopiskelubusinessPsychologyKasvatustieteet - Educational sciences0503 educationproblematic progression of studies050104 developmental & child psychologyat-risk students
researchProduct

Immune effects of 5-fluorouracil

2012

Cytotoxic anticancer drugs can promote antitumor immune responses. The anticancer activity of 5-fluorouracil (5FU) relies on the restoration of T-cell immunity following the elimination of myeloid-derived suppressor cells (MDSCs). We have recently discovered that the 5FU-driven activation of the NLRP3 inflammasome in MDSCs promotes tumor angiogenesis by eliciting TH17 responses that compromise anticancer immunity. This underscores the need to combine 5-FU with NLRP3 inhibitors to prevent tumor progression.

IL1business.industryImmunologychemical and pharmacologic phenomenaInflammasomemyeloid derived suppressor cellsfluorouracillaw.inventionImmune systemNLRP3OncologyinflammasomelawTumor progressionImmunityFluorouracilImmunologyMyeloid-derived Suppressor CellmedicineImmunology and AllergyCytotoxic T cellSuppressorbusinessAuthor's Viewmedicine.drugOncoImmunology
researchProduct

Microradiography and confocal laser scanning microscopy applied to enamel lesions formed in vivo with and without fluoride varnish treatment

1996

The aim of the present investigation was to combine 2 techniques suitable for lesion characterization: quantitative microradiography (TMR) and confocal laser scanning microscopy (CLSM) on in vivo induced lesions with and without a fluoride varnish (Duraphat(R)) treatment. Orthodontic bands were attached to premolars to be extracted for orthodontic reasons to induce enamel caries on the buccal surfaces. In the caries development part of the study, 1 tooth of each pair received at the start 1 topical application with the fluoride varnish Duraphat(R), the contralateral tooth serving as untreated control. All teeth were extracted after 4 weeks. In the caries progression part, the premolars were…

INVIVODentistrymicroradiographychemistry.chemical_compoundPaintPremolarChemical PrecipitationScattering RadiationFluorides TopicalChildTooth DemineralizationOrthodonticsMineralsconfocal laser scanning microscopyMicroscopy ConfocalSOUNDEnamel paintCARIESdemineralizationDURAPHATmedicine.anatomical_structureLIGHTvisual_artvisual_art.visual_art_mediumDisease Progressionmedicine.symptomcarious lesionFluorideAdolescentConfocalDental CariesLesionOrthodontic Appliancesstomatognathic systemmedicineHumansBicuspidDental EnamelGeneral DentistryINSITUINVITRObusiness.industryFluoride varnishfluoride varnishBuccal administrationDemineralizationstomatognathic diseaseschemistrySodium FluoridebusinessEuropean Journal of Oral Sciences
researchProduct

Predicting Gleason Group Progression for Men on Prostate Cancer Active Surveillance: Role of a Negative Confirmatory Magnetic Resonance Imaging-Ultra…

2018

Active surveillance has gained acceptance as an alternative to definitive therapy in many men with prostate cancer. Confirmatory biopsies to assess the appropriateness of active surveillance are routinely performed and negative biopsies are regarded as a favorable prognostic indicator. We sought to determine the prognostic implications of negative multiparametric magnetic resonance imaging-transrectal ultrasound guided fusion biopsy consisting of extended sextant, systematic biopsy plus multiparametric magnetic resonance imaging guided targeted biopsy of suspicious lesions on magnetic resonance imaging.All patients referred with Gleason Grade Group 1 or 2 prostate cancer based on systematic…

Image-Guided BiopsyMalemedicine.medical_specialtyUrologymedicine.medical_treatment030232 urology & nephrology03 medical and health sciencesProstate cancer0302 clinical medicineBiopsyMedicineHumansProspective StudiesProspective cohort studyWatchful WaitingMultiparametric Magnetic Resonance ImagingUltrasonography InterventionalAgedRetrospective Studiesmedicine.diagnostic_testbusiness.industryProstateProstatic NeoplasmsMagnetic resonance imagingRetrospective cohort studyMiddle Agedmedicine.diseasePrognosisMagnetic Resonance ImagingDisease ProgressionRadiologyNeoplasm GradingbusinessImage-Guided BiopsyWatchful waitingThe Journal of urology
researchProduct

Resistance of Cancer Stem Cells to Cell-Mediated Immune Responses

2015

In the past decades, the hierarchical organization of tumors, governed by Cancer Stem Cells (CSCs), have been reported with regard to several tumor types. Advances in sequencing technologies have demonstrated that diverse genetic CSCs subclones, derived from the branching evolution, compete with each other within the tumor mass, thereby contributing to the functional heterogeneity. It is becoming increasingly clear that epigenetic modifications and microenvironmental influences are important determinants of tumor fitness resulting in disease progression, recurrence and reduced patient survival. Therefore, more effective therapies will require gaining insights into the role of genetic and no…

Immune systemCancer stem cellDisease progressionCancer researchImmune escapePatient survivalEpigeneticsBiologyAcquired immune systemCell mediated immunity
researchProduct

Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individuals.

2015

Altered interplay between gut mucosa and microbiota during treated HIV infection may possibly contribute to increased bacterial translocation and chronic immune activation, both of which are predictors of morbidity and mortality. Although a dysbiotic gut microbiota has recently been reported in HIV + individuals, the metagenome gene pool associated with HIV infection remains unknown. The aim of this study is to characterize the functional gene content of gut microbiota in HIV + patients and to define the metabolic pathways of this bacterial community, which is potentially associated with immune dysfunction. We determined systemic markers of innate and adaptive immunity in a cohort of HIV-in…

ImmunologyHIV InfectionsBiologyGut floraAdaptive ImmunityMicrobiologyMetabolomicsImmunityAntiretroviral Therapy Highly ActiveRNA Ribosomal 16SMetabolomeImmunology and AllergyCluster AnalysisHumansMetabolomicsGeneCase-control studyBayes TheoremBiodiversityAcquired immune systembiology.organism_classificationImmunity InnateMarkov ChainsGastrointestinal MicrobiomeMetabolic pathwayCase-Control StudiesImmunologyDisease ProgressionHIV-1MetabolomeMetagenomeMucosal immunology
researchProduct

Stanley Fahn Lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered.

2006

The synucleinopathy known as sporadic Parkinson's disease (PD) is a multisystem disorder that severely damages predisposed nerve cell types in circumscribed regions of the human nervous system. A recent staging procedure for the inclusion body pathology associated with PD proposes that, in the brain, the pathological process (formation of proteinaceous intraneuronal Lewy bodies and Lewy neurites) begins at two sites and continues in a topographically predictable sequence in six stages, during which components of the olfactory, autonomic, limbic, and somatomotor systems become progressively involved. In stages 1 to 2, the Lewy body pathology is confined to the medulla oblongata/pontine tegme…

Inclusion BodiesPathologymedicine.medical_specialtyParkinson's diseaseLewy bodyAnatomical pathologySubstantia nigraParkinson Diseasemedicine.diseaseCentral nervous system diseaseDegenerative diseasenervous systemNeurologyForebrainmedicineTegmentumDisease ProgressionAnimalsHumansNeurology (clinical)PsychologyNeuroscienceMovement disorders : official journal of the Movement Disorder Society
researchProduct

Geldanamycin and its derivatives as Hsp90 inhibitors

2012

The Hsp90 molecule, one of the most abundant heat shock proteins in mammalian cells, maintains homeostasis and prevents stress-induced cellular damage. Hsp90 is expressed under normal conditions at a level of about 1-2 Percent of total proteins, while its expression increases 2-10 fold in cancer cells. The two main constitutively expressed isoforms of Hsp90 are known as Hsp90-alpha and Hsp90-beta, and their upregulation is associated with tumor progression, invasion and formation of metastases, as well as development of drug resistance. The Hsp90 is a key target for many newly established, potent anticancer agents containing Hsp90 N-terminal ATP binding inhibitors, such as geldanamycin, and…

IndolesLactams MacrocyclicCyclin-Dependent KinaseAntineoplastic AgentsTanespimycinBenzoquinoneModels BiologicalAntineoplastic Agentchemistry.chemical_compoundDownregulation and upregulationTransforming Growth Factor betaCyclin-dependent kinaseHeat shock proteinBenzoquinonespolycyclic compoundsAnimalsHumansHSP90 Heat-Shock ProteinsbiologyAnimalTriazolesGeldanamycinHsp90Cyclin-Dependent KinasesProto-Oncogene Proteins c-rafHSP90 Heat-Shock Proteinsrc-Family KinaseschemistryTumor progressionMutationCancer cellbiology.proteinCancer researchMacrolidesMacrolideTriazoleTumor Suppressor Protein p53Animals; Antineoplastic Agents; Benzoquinones; Cyclin-Dependent Kinases; HSP90 Heat-Shock Proteins; Humans; Lactams Macrocyclic; Macrolides; Models Biological; Mutation; Novobiocin; Proto-Oncogene Proteins c-raf; Transforming Growth Factor beta; Triazoles; Tumor Suppressor Protein p53; src-Family KinasesNovobiocinHumanFrontiers in Bioscience
researchProduct

Communication and ethical considerations for fertility preservation for patients with childhood, adolescent, and young adult cancer

2021

Patients with childhood, adolescent, and young adult cancer who will be treated with gonadotoxic therapies are at increased risk for infertility. Many patients and their families desire biological children but effective communication about treatment-related infertility risk and procedures for fertility preservation does not always happen. The PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group reviewed the literature and developed a clinical practice guideline that provides recommendations for ongoing communication methods for fertility preservation for patients who were diagnosed with childhood, adolescent, and young adult cancer at a…

InfertilityAdultMalemedicine.medical_specialtyAdolescentfertility preservationmedia_common.quotation_subjectMEDLINEMedizinFertilityGuidelines as Topic03 medical and health sciences0302 clinical medicineCancer SurvivorsSDG 3 - Good Health and Well-beingNeoplasmsMedicineHumansgonadotoxic therapiesFertility preservationYoung adultGrading (education)Childmedia_commonchildhoodCancer030219 obstetrics & reproductive medicinebusiness.industryCancerGuidelinemedicine.diseaseOncology030220 oncology & carcinogenesisFamily medicineDisease Progressionyoung adultFemalebusinessinfertilityreproductive medicineThe Lancet Oncology
researchProduct

Association of redox and inflammation-related biomarkers with prognosis in IgA nephropathy: A prospective observational study.

2022

IgA nephropathy (IGAN) has a variable prognosis. Risk stratification tools are usually based on clinical parameters combined with histologic Oxford-MEST-C score. Circulating redox- and inflammation-related biomarkers may be related to histological changes in IGAN. Therefore, we studied the performance of these biomarkers in predicting the rate of GFR-loss in IGAN.This was an observational prospective study. Fifty-seven stable patients with IGAN were examined at baseline and after a mean observational time of 5.9 ± 1.1 years. The main outcome measure was eGFR-loss per year with predefined groups, stable (1.5 ml/min/1,73 mFifteen patients were in the progressive, 11 in the intermediate, and 3…

InflammationGlomerulonephritis IGABiochemistryAdvanced Oxidation Protein ProductsReceptors Tumor Necrosis Factor Type IPhysiology (medical)Disease ProgressionHumansVDP::Medisinske Fag: 700OsteopontinCysteineProspective StudiesOxidation-ReductionBiomarkersGlomerular Filtration RateFree radical biologymedicine
researchProduct